phrykt

Vertex Pharmaceuticals Inc / Ma (VRTX) share buybacks: $2B

Vertex Pharmaceuticals Inc / Ma spent $2B buying back its own shares in the year ended Dec 31, 2025, up 71.4% from $1.2B a year earlier.

From Vertex Pharmaceuticals Inc / Ma's filings with the SEC · Read the filing · VRTX stock page

Vertex Pharmaceuticals Inc / Ma share buybacks by year

$1.4B2021$428M2023$1.2B2024$2B2025

#111 of 1,890 US companies by share buybacks · See the full ranking

Year endedShare buybacksChange
Dec 31, 2025$2B+71%
Dec 31, 2024$1.2B+175%
Dec 31, 2023$428M-70%
Dec 31, 2021$1.4B–

Share buybacks of similar companies

Companies in the same industry as Vertex Pharmaceuticals Inc / Ma, by SEC industry code, with the closest share buybacks. Each name opens the same page for that company.

CompanyShare buybacks, latest yearYear ended
Eli Lilly$4.1BDec 31, 2025
Regeneron Pharmaceuticals$3.4BDec 31, 2025
Zoetis$3.2BDec 31, 2025
Vertex Pharmaceuticals Inc / Ma$2BDec 31, 2025
Royalty Pharma$1.2BDec 31, 2025
United Therapeutics$1BDec 31, 2025
AbbVie$980MDec 31, 2025

Questions and answers

What is Vertex Pharmaceuticals Inc / Ma's share buybacks?

Vertex Pharmaceuticals Inc / Ma spent $2B buying back its own shares in the year ended Dec 31, 2025, up 71.4% from $1.2B a year earlier.

Numbers as reported in Vertex Pharmaceuticals Inc / Ma's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology